Literature DB >> 22311413

Relation between FDG uptake and apparent diffusion coefficients in glioma and malignant lymphoma.

Nobuyoshi Matsushima1, Masayuki Maeda, Maki Umino, Naohisa Suzawa, Tomomi Yamada, Kan Takeda.   

Abstract

OBJECTIVE: This study evaluates the relation between 2-deoxy-2-[18F]fluoro-D: -glucose (FDG) uptake using positron emission tomography/CT and the apparent diffusion coefficient (ADC) in patients with glioma and malignant lymphoma.
METHODS: For 36 patients (30 with glioma and 6 with malignant lymphoma), the standardized uptake value (SUV) ratio was calculated to assess the FDG uptake. Pearson's correlation analysis was used to assess the relation between the SUV ratio and the ADC value: those of low-grade glioma and high-grade glioma were compared, as were those of glioblastoma and malignant lymphoma.
RESULTS: Inverse correlation between the SUV ratio and the minimum ADC was found for all cases (P < 0.0001, r = 0.68) and for glioma cases (P < 0.0001, r = 0.67). High-grade gliomas showed a significantly higher SUV ratio than low-grade gliomas did (P < 0.0001); they also showed significantly lower minimum ADC than low-grade gliomas did (P < 0.001). Cut-off values used for the SUV ratio of 0.9 and for the minimum ADC of 0.99 × 10(-3 )mm(2)/s were used to differentiate high-grade from low-grade gliomas, with high accuracy. Malignant lymphoma showed a significantly higher SUV ratio than glioblastoma (P < 0.0001). No significant difference in the ADC value was found between glioblastoma and malignant lymphoma (the minimum ADC: P = 0.13, the mean ADC: P = 0.084, respectively).
CONCLUSIONS: An inverse correlation was found between the SUV ratio and the minimum ADC in glioma and malignant lymphoma. The SUV ratio and the minimum ADC are useful to evaluate the grading of gliomas. The SUV ratio might be more useful for differentiating malignant lymphoma from glioblastoma than the ADC value is.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22311413     DOI: 10.1007/s12149-012-0570-y

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  10 in total

Review 1.  Imaging and evaluation of patients with high-risk prostate cancer.

Authors:  Marc A Bjurlin; Andrew B Rosenkrantz; Luis S Beltran; Roy A Raad; Samir S Taneja
Journal:  Nat Rev Urol       Date:  2015-10-20       Impact factor: 14.432

2.  Accuracy of apparent diffusion coefficients and enhancement ratios on magnetic resonance imaging in differentiating primary cerebral lymphomas from glioblastoma.

Authors:  Shayan Sirat Maheen Anwar; Mirza Zain Baig; Altaf Ali Laghari; Fatima Mubarak; Muhammad Shahzad Shamim; Umaima Ayesha Jilani; Muhammad Usman Khalid
Journal:  Neuroradiol J       Date:  2019-06-12

3.  Tumor hypoxia and microscopic diffusion capacity in brain tumors: a comparison of (62)Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET/CT and diffusion-weighted MR imaging.

Authors:  Ayako Hino-Shishikura; Ukihide Tateishi; Hirofumi Shibata; Tomohiro Yoneyama; Toshiaki Nishii; Ikuo Torii; Kensuke Tateishi; Makoto Ohtake; Nobutaka Kawahara; Tomio Inoue
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-10       Impact factor: 9.236

4.  Diffusivity of intraorbital lymphoma vs. IgG4-related DISEASE: 3D turbo field echo with diffusion-sensitised driven-equilibrium preparation technique.

Authors:  Akio Hiwatashi; Takashi Yoshiura; Osamu Togao; Koji Yamashita; Kazufumi Kikuchi; Yoko Fujita; Hiroshi Yoshikawa; Takaomi Koga; Makoto Obara; Hiroshi Honda
Journal:  Eur Radiol       Date:  2013-11-06       Impact factor: 5.315

5.  Primary central nervous system lymphoma: is absence of intratumoral hemorrhage a characteristic finding on MRI?

Authors:  Akihiko Sakata; Tomohisa Okada; Akira Yamamoto; Mitsunori Kanagaki; Yasutaka Fushimi; Toshiki Dodo; Yoshiki Arakawa; Jun C Takahashi; Susumu Miyamoto; Kaori Togashi
Journal:  Radiol Oncol       Date:  2015-03-25       Impact factor: 2.991

6.  Differentiation between Glioblastoma Multiforme and Primary Cerebral Lymphoma: Additional Benefits of Quantitative Diffusion-Weighted MR Imaging.

Authors:  Ching Chung Ko; Ming Hong Tai; Chien Feng Li; Tai Yuan Chen; Jeon Hor Chen; Ginger Shu; Yu Ting Kuo; Yu Chang Lee
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

Review 7.  Meta-Analysis of the Correlation between Apparent Diffusion Coefficient and Standardized Uptake Value in Malignant Disease.

Authors:  Shengming Deng; Zhifang Wu; Yiwei Wu; Wei Zhang; Jihui Li; Na Dai; Bin Zhang; Jianhua Yan
Journal:  Contrast Media Mol Imaging       Date:  2017-02-26       Impact factor: 3.161

8.  Use of 18F-FDG-PET/CT in differential diagnosis of primary central nervous system lymphoma and high-grade gliomas: A meta-analysis.

Authors:  Guisheng Zhang; Jiuhong Li; Xuhui Hui
Journal:  Front Neurol       Date:  2022-08-17       Impact factor: 4.086

9.  Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma-a narrative review.

Authors:  Simone Krebs; Julia G Barasch; Robert J Young; Christian Grommes; Heiko Schöder
Journal:  Ann Lymphoma       Date:  2021-06-30

10.  Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.

Authors:  Huafeng Wang; Ming Wang; Juying Wei; Lei Wang; Liping Mao; Jie Jin
Journal:  J Int Med Res       Date:  2017-10-06       Impact factor: 1.671

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.